Sri Lanka: Long Term Medical Support and Growth Hormone Treatment for Children

Updates on 4 Children in Program: Q1 2017

June 10, 2017

Stephney Minerva Fernando

Madumekala standing tall

Madumekala standing tall

Madumekala Ubeywarna

JANUARY 2017

  • Madumekala is a 23-year-old young woman. She came to the meeting with her mother. She received 5 vials of growth hormone (GH) for the month of January, and she visited the clinic in Karapitiya twice.
  • Madumekala is continuing sex hormone medication: estrogen, 1 tablet daily. Her bone age is 11 years. It is below her chronological age. Madumekala was treated by Dr. Manilka Sumanthilaka, a consultant endocrinologist. He again referred Madumekala to Professor Sujeewa for further treatment.
  • As Professor Sujeewa instructed, Madumekala’s growth hormone therapy was increased again from 14 clicks to 16 clicks from January 14th, 2016. She needs 5 vials of growth hormone (GH) for each month. After completing one year, her height is improving now.
  • Dr. Nayananjani Karunasena, an endocrinologist, revealed that Madumekala’s last convulsion attack was on May 21, 2013.
  • Madumekala is given 75 mg thyroxine in the morning.
  • Madumekala is given 5 mg hydrocortisone in the morning and 2.5 mg hydrocortisone at night.
  • Madumekala is given 100 mg sodium valproate in the morning and 200 mg sodium valproate at night.
  • The Climen tablet given to Madumekala was changed to an estrogen tablet.

FEBRUARY 2017

  • Madumekala is a 23-year-old young woman. She received 5 vials of growth hormone (GH) for the month of February, and she visited the clinic twice.
  • Madumekala is continuing sex hormone medication: estrogen, 1 tablet daily. Her bone age is 11 years. It is below her chronological age. Madumekala was treated by Dr. Manilka Sumanthilaka, a consultant endocrinologist. He again referred Madumekala to Professor Sujeewa for further treatment.
  • As Professor Sujeewa instructed, Madumekala’s growth hormone therapy was increased again from 14 clicks to 16 clicks from January 14th, 2016. She needs 5 vials of growth hormone (GH) for each month. After completing one year, her height is improving now.
  • Dr. Nayananjani Karunasena, an endocrinologist, revealed that Madumekala’s last convulsion attack was on May 21, 2013.
  • Madumekala is given 75 mg thyroxine in the morning.
  • Madumekala is given 5 mg hydrocortisone in the morning and 2.5 mg hydrocortisone at night.
  • Madumekala is given 100 mg sodium valproate in the morning and 200 mg sodium valproate at night.
  • The Climen tablet given to Madumekala was changed to an estrogen tablet.
  • Madumekala’s food parcel was changed slightly; instead of red rice, she is given more milk powder, salmon, and cheese. This change makes the food parcel easier for her to take to Galle.

MARCH 2017

  • Madumekala is a 23-year-old young woman. She came late to the meeting with her mother because of her father’s tragic death. She received 5 vials of growth hormone (GH) for the month of March, and she visited the clinic twice.
  • Madumekala is continuing sex hormone medication: estrogen, 1 tablet daily. Her bone age is 11 years. It is below her chronological age. Madumekala was treated by Dr. Manilka Sumanthilaka, a consultant endocrinologist. He again referred Madumekala to Professor Sujeewa for further treatment.
  • As Professor Sujeewa instructed, Madumekala’s growth hormone therapy was increased again from 14 clicks to 16 clicks from January 14th, 2016. She needs 5 vials of growth hormone (GH) for each month. After completing one year, her height is improving now.
  • Dr. Nayananjani Karunasena, an endocrinologist, revealed that Madumekala’s last convulsion attack was on May 21, 2013.
  • Madumekala is given 75 mg thyroxine in the morning.
  • Madumekala is given 5 mg hydrocortisone in the morning and 2.5 mg hydrocortisone at night.
  • Madumekala is given 100 mg sodium valproate in the morning and 200 mg sodium valproate at night.
  • The Climen tablet given to Madumekala was changed to an estrogen tablet.
  • Madumekala’s food parcel was changed slightly; instead of red rice, she is given more milk powder, salmon, and cheese. This change makes the food parcel easier for her to take to Galle.
Madura’s mother receives the food parcel from Nishantha

Madura’s mother receives the food parcel from Nishantha

Madura Madushanka

JANUARY 2017

  • Madura received 4 vials of growth hormone (GH) for the month of January.
  • He had attended school and private classes and completed the Advanced Level Exam. At the moment, he is taking a computer course.
  • His mother is very much concerned with his progress, and the medical authorities at Karapitiya Teaching Hospital are very satisfied with her.

FEBRUARY 2017

  • Madura received 4 vials of growth hormone (GH) for the month of February.
  • He had attended school and private classes and completed the Advanced Level Exam. At the moment, he is taking a computer course.
  • His mother is very much concerned with his progress, and the medical authorities at Karapitiya Teaching Hospital are very satisfied with her.

MARCH 2017

  • Madura received 4 vials of growth hormone (GH) for the month of March.
  • He had attended school and private classes and completed the Advanced Level Exam. At the moment, he is taking a computer course.
  • His mother is very much concerned with his progress, and the medical authorities at Karapitiya Teaching Hospital are very satisfied with her.
Gayan with his food parcel

Gayan with his food parcel

Gayan Madushanka

JANUARY 2017

  • For the month of January, Gayan did not receive any vials of growth hormone (GH). After observing the progress of Gayan’s height, Professor Sujeewa had instructed to stop therapy for him. Gayan visited the clinic at Karapitiya once to get the Testoviron injection.
  • Gayan had stopped attending school. He is now working as a helper.
  • Gayan visited the clinic at Karapitiya for his Testoviron injection on January 10th. He has had no complaints and no problems with stunting.

FEBRUARY 2017

  • For the month of February, Gayan did not receive any vials of growth hormone (GH). After observing the progress of Gayan’s height, Professor Sujeewa had instructed to stop therapy for him. Gayan visited the clinic at Karapitiya once to get the Testoviron injection.
  • Gayan visited the clinic at Karapitiya for his Testoviron injection on February 7th. He has had no complaints and no problems with stunting.

MARCH 2017

  • For the month of March, Gayan did not receive any vials of growth hormone (GH). After observing the progress of Gayan’s height, Professor Sujeewa had instructed to stop therapy for him. Gayan visited the clinic at Karapitiya once to get the Testoviron injection.
  • Gayan visited the clinic at Karapitiya for his Testoviron injection on March 2nd. He has had no complaints and no problems with stunting.
Tharindu with his food parcel

Tharindu with his food parcel

Tharindu Hasanga

JANUARY 2017

  • Tharindu’s increased medication had to continue. He visited the Karapitiya clinic with his new blood profile in January 2017, and he met with the medical consultant. The new blood profile helped to monitor Tharindu’s cholesterol levels. After 3 months, he will need to visit the Karapitiya clinic again with a new blood profile. Before that, Tharindu must have another blood profile in February.
  • Tharindu’s cholesterol level was low, but there was no change in his medication. Senior medical consultant, Dr. Arosha, had instructed Tharindu to do more exercises, such as cycling, to decrease his weight. Tharindu’s weight has decreased by several kilograms. The medical consultant had given Tharindu a diet system, and he must eat what is listed on the chart.
  • Professor Sujeewa Amarasinghe, the senior pediatrician at Karapitiya Teaching Hospital in Galle, Sri Lanka, had referred Tharindu to Dr. Arosha.
  • Tharindu takes Rosuvastatin (40 mg) and Ezetimibe (10 mg) each night. He also receives a food parcel with more grains and a packet of fat-free milk powder. For his food parcel, we also reduced the quantity of red rice and had added soy protein as instructed by Dr. Arosha.

FEBRUARY 2017

  • Tharindu’s increased medication had to continue. He visited the Karapitiya clinic with his new blood profile in February 2017, and he met with the medical consultant. The new blood profile helped to monitor Tharindu’s cholesterol levels. After 3 months, he will need to visit the Karapitiya clinic again with a new blood profile. Tharindu was supposed to have another blood profile in February, but he informed them he would visit the clinic the first week of March.
  • Tharindu’s cholesterol level was low, but there was no change in his medication. Senior medical consultant, Dr. Arosha, had instructed Tharindu to do more exercises, such as cycling, to decrease his weight. Tharindu’s weight has decreased by several kilograms. The medical consultant had given Tharindu a diet system, and he must eat what is listed on the chart.
  • Professor Sujeewa Amarasinghe, the senior pediatrician at Karapitiya Teaching Hospital in Galle, Sri Lanka, had referred Tharindu to Dr. Arosha.
  • Tharindu takes Rosuvastatin (40 mg) and Ezetimibe (10 mg) each night. He also receives a food parcel with more grains and a packet of fat-free milk powder. For his food parcel, we also reduced the quantity of red rice and had added soy protein as instructed by Dr. Arosha.

MARCH 2017

  • Tharindu’s increased medication had to continue. He visited the Karapitiya clinic with his new blood profile in March 2017, and he met with the medical consultant. The new blood profile helped to monitor Tharindu’s cholesterol levels. After 3 months, he will need to visit the Karapitiya clinic again with a new blood profile.
  • Tharindu’s cholesterol level was low, but there was no change in his medication. Senior medical consultant, Dr. Arosha, had instructed Tharindu to do more exercises, such as cycling, to decrease his weight. Tharindu’s weight has decreased by several kilograms. The medical consultant had given Tharindu a diet system, and he must eat what is listed on the chart.
  • Professor Sujeewa Amarasinghe, the senior pediatrician at Karapitiya Teaching Hospital in Galle, Sri Lanka, had referred Tharindu to Dr. Arosha.
  • Tharindu takes Rosuvastatin (40 mg) and Ezetimibe (10 mg) each night. He also receives a food parcel with more grains and a packet of fat-free milk powder. For his food parcel, we also reduced the quantity of red rice and had added soy protein as instructed by Dr. Arosha.

Fazeer Ahamed

 JANUARY 2017

  • Fazeer did not attend the monthly meeting in January, and we received no information from him. He did not receive his 4 vials of growth hormone therapy for the month of January.
  • We did not purchase Fazeer’s 4 vials of growth hormone for the month of January 2017, and we instructed the medical authority of Ward No.1 not to issue the vials, as Fazeer must meet with us in Tangalle before going to the clinic in Karapitiya.
  • Fazeer’s dosage is 10 clicks at night, daily. Since he did not attend the monthly meeting, Fazeer was not provided with a food parcel for the month of January.

FEBRUARY 2017

  • Fazeer is no longer a beneficiary of the long-term medical support program.

MARCH 2017

  •  Fazeer is no longer a beneficiary of the long-term medical support program.